Sunhydrogen, Inc. financial data

Symbol
HYSR on OTC
Location
Bioventures Center, 2500 Crosspark Road, Coralville, IA
Fiscal year end
June 30
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 1.61 % +14.1%
Return On Assets -20.3 % +19.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.44B shares +4.47%
Common Stock, Shares, Outstanding 5.44B shares +4.47%
Entity Public Float 123M USD +88.9%
Common Stock, Value, Issued 5.44M USD +4.47%
Weighted Average Number of Shares Outstanding, Basic 5.44B shares +6.58%
Weighted Average Number of Shares Outstanding, Diluted 5.44B shares +6.58%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.25K USD
Research and Development Expense 4.03M USD +47.3%
Selling and Marketing Expense 10.5K USD +2831%
General and Administrative Expense 2.62M USD +16.5%
Operating Income (Loss) -6.7M USD -33%
Nonoperating Income (Expense) 363K USD
Net Income (Loss) Attributable to Parent -7.74M USD +32.6%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 33.5M USD
Marketable Securities, Current 3.19M USD -86.9%
Cash, Cash Equivalents, and Short-term Investments 2.98M USD
Accounts Receivable, after Allowance for Credit Loss, Current 1.25K USD
Assets, Current 35.5M USD
Property, Plant and Equipment, Net 140K USD -9.97%
Other Assets, Noncurrent 3M USD
Assets 35.7M USD -17.6%
Accounts Payable, Current 469K USD +88.6%
Accrued Liabilities, Current 98.7K USD +16.8%
Liabilities, Current 760K USD +123%
Liabilities 767K USD +30.7%
Retained Earnings (Accumulated Deficit) -102M USD -8.24%
Stockholders' Equity Attributable to Parent 34.5M USD -17.8%
Liabilities and Equity 35.7M USD -17.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.19M USD -68.5%
Net Cash Provided by (Used in) Financing Activities -1M USD -146%
Net Cash Provided by (Used in) Investing Activities 1.02M USD
Common Stock, Shares Authorized 10B shares 0%
Common Stock, Shares, Issued 5.44B shares +4.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 33.5M USD -17.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 543 USD -67.9%
Deferred Tax Assets, Valuation Allowance 6.43M USD +1.58%
Depreciation 8.53K USD +11.1%
Property, Plant and Equipment, Gross 189K USD +2.98%
Deferred Tax Assets, Operating Loss Carryforwards 6.43M USD +21%
Preferred Stock, Shares Issued 11K shares 0%
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 131M USD +0.05%
Amortization of Intangible Assets 1.67K USD -0.06%
Depreciation, Depletion and Amortization 11K USD +6.63%
Share-based Payment Arrangement, Expense 279K USD +2699%
Interest Expense 12.8K USD -93.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%